Clinical trial

Beta Cell Function Tests Over Time In Patients With T2dm Randomized To Metformin Or Rosiglitazone

NCT00282945

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2006-01-01

PhaseNA

Study timeline

Study start (unknown)2006-01-01Date precision: month

Registry last updated2008-10-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Interventions

RosiglitazoneDRUG · verified · RxNorm: rosiglitazone

MetforminDRUG · verified · RxNorm: metformin

Sponsors & collaborators

Pfizerlead sponsor

Mapped research locations

JerusalemIsrael1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00282945 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.